What is Ligand Pharmaceuticals's PP&E (net)?

Ligand Pharmaceuticals (LGND) reported PP&E (net) of $3.44M in Q1 2026.

How has Ligand Pharmaceuticals's PP&E (net) changed year-over-year?

Ligand Pharmaceuticals's PP&E (net) decreased by 4.9% year-over-year, from $3.62M to $3.44M.

What is the long-term trend for Ligand Pharmaceuticals's PP&E (net)?

Over 5 years (2020 to 2025), Ligand Pharmaceuticals's PP&E (net) has grown at a -23.0% compound annual growth rate (CAGR), from $13.19M to $3.57M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ligand Pharmaceuticals LGND PP&E (Net)

PP&E (Net) at other companies

LQD

Liquidia CorporationLQDA

$20.84M+146%

RevvityRVTY

$465.64M-4.3%

BridgeBio PharmaBBIO

$4.94M-26.2%

Roivant SciencesROIV

$11.99M-0.6%

Relay Therapeutics, Inc.RLAY

$1.22M-76.3%

Kiniksa Pharmaceuticals International, plcKNSA

$1.99M+228%

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.6B+96.7%

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's PP&E (net)?: Ligand Pharmaceuticals (LGND) reported PP&E (net) of $3.44M in Q1 2026.
How has Ligand Pharmaceuticals's PP&E (net) changed year-over-year?: Ligand Pharmaceuticals's PP&E (net) decreased by 4.9% year-over-year, from $3.62M to $3.44M.
What is the long-term trend for Ligand Pharmaceuticals's PP&E (net)?: Over 5 years (2020 to 2025), Ligand Pharmaceuticals's PP&E (net) has grown at a -23.0% compound annual growth rate (CAGR), from $13.19M to $3.57M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.